CureVac
(NASDAQ) CVAC
This security has been delisted. This page is retained for historical reference.
CVAC News
Why CureVac Stock Plunged Today
Why CureVac Stock Is Sinking Today
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowCVAC Financials
Key Financial Metrics (TTM)
Gross Margin
93.00%
Operating Margin
212.01%
Net Income Margin
182.11%
Return on Equity
18.40%
Return on Capital
24.16%
Return on Assets
11.31%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
€65.79M
Operating Income
€149.98M
EBITDA
€181.23M
Operating Cash Flow
-€120.14M
Capital Expenditure
-€4.96M
Free Cash Flow
-€125.10M
Cash & ST Invst.
€419.21M
Total Debt
€35.07M
CureVac Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€54.13M
-89.0%
Gross Profit
€53.76M
-88.6%
Gross Margin
99.31%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
825
N/A
Net Income
€273.23M
-19.2%
EBITDA
€317.86M
-15.3%
Quarterly Fundamentals
Total Cash
€419.21M
-24.5%
Total Debt
€35.07M
-12.6%
Accounts Receivable
€27.36M
+31.5%
Inventory
€541.00K
+15.1%
Long Term Debt
€30.30M
-13.2%
Short Term Debt
€4.77M
-8.9%
Return on Assets
11.31%
N/A
Return on Invested Capital
16.62%
N/A
Free Cash Flow
€29.54M
-91.6%
Operating Cash Flow
€29.86M
-91.6%